JPRN-jRCT2080222754已完成3 期
A long-term extension study for the phase 3 study of nalmefene (339-14-001) in patients with alcohol dependence
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 405
研究概览
简要总结
The efficacy in reducing alcohol consumption was sustained by long-term treatment with nalmefene. Long-term treatment with nalmefene showed no notable safety concerns and was well tolerated by patients with alcohol dependence.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who have completed Study 339-14-001.
- •- Patients who have signed the informed consent form for Study 339-14-002.
排除标准
- •- The patient has a clinically significant unstable illness (eg, complication of New York Heart Association (NYHA) class 3 or 4 heart failure or angina pectoris, renal function disorder with estimated glomerular filtration rate (eGFR) of under 30 mL/min/1.73 m2, hepatic failure, and neoplastic disorder).
- •- The patient has a clinically significant abnormal electrocardiogram (ECG) which is inappropriate for the participation in the trial in the opinion of the investigator or subinvestigator.
研究者
相似试验
已完成
3 期
A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol DependenceAlcohol DependenceNCT02382276Otsuka Pharmaceutical Co., Ltd.405
已完成
3 期
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)Attention-deficit/Hyperactivity DisorderNCT01081145Shire528
Unknown
4 期
EFFORT Extension StudyHepatitis B, ChronicNCT01529255Nanfang Hospital, Southern Medical University576
进行中（未招募）
2 期
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical TrialsDermatitis AtopicNCT05492578Sanofi1,856
已完成
3 期
Combined Study - Phase 3b MenB Long Term Persistence in AdolescentsInfections, MeningococcalNCT02446743GlaxoSmithKline531